Veraxa Biotech Holding AG (VRXA) Cash from Financing Activities (2025)

Veraxa Biotech Holding AG (VRXA) posted Cash from Financing Activities of $125117.0 for Q4 2025.

Veraxa Biotech Holding AG (VRXA) Cash from Financing Activities (2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXA) has reported Cash from Financing Activities for 1 consecutive years, with $125117.0 the latest figure, recorded in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 125,116.98
Dec 31, 2025 125,116.98